These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16175953)

  • 21. Fictitious pseudohyperkalemia due to the dilution of plasma by anticoagulant.
    Han SW; Park JI; Yi JH; Park IK; Kim HJ
    Clin Nephrol; 2009 Aug; 72(2):156-7. PubMed ID: 19640375
    [No Abstract]   [Full Text] [Related]  

  • 22. Pseudohyperkalemia in thrombocythemia.
    Mak WL; Mok CK
    Chin Med J (Engl); 2001 Nov; 114(11):1216-7. PubMed ID: 11729525
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pseudohyperkalemia and thrombocytosis].
    Le Goff E; Jondeau K; Venon MD; Greffe S; Ronez E; Ngo S; Kahn JE; Hanslik T
    Rev Med Interne; 2021 Jun; 42(6):438-441. PubMed ID: 33531232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis.
    Fukasawa H; Furuya R; Kato A; Yonemura K; Fujigaki Y; Yamamoto T; Hishida A
    Clin Nephrol; 2002 Dec; 58(6):451-4. PubMed ID: 12508968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudohyperkalemia: A new twist on an old phenomenon.
    Meng QH; Wagar EA
    Crit Rev Clin Lab Sci; 2015; 52(2):45-55. PubMed ID: 25319088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudohyperkalemia - Potassium released from cells due to clotting and centrifugation - a case report.
    Šálek T
    Biochem Med (Zagreb); 2018 Feb; 28(1):011002. PubMed ID: 29472808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe post-splenectomy hepatic insufficiency in a patient with agnogenic myeloid metaplasia].
    Pérez-Villa F; Font J; Feliu E; Campo E; Ingelmo M
    Med Clin (Barc); 1988 Jun; 91(3):108-10. PubMed ID: 3172909
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia.
    Bnaya A; Ruchlemer R; Itzkowitz E; Gabbay E; Mosenkis A; Shavit L
    Int J Hematol; 2021 Jul; 114(1):102-108. PubMed ID: 33782816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudohyperkalemia in Chronic Lymphocytic Leukemia. Longitudinal Analysis and Review of the Literature.
    Katkish L; Rector T; Ishani A; Gupta P
    Minn Med; 2015 Jul; 98(7):45-6. PubMed ID: 26267922
    [No Abstract]   [Full Text] [Related]  

  • 30. [Portal hypertension after splenectomy for myeloid splenomegaly].
    Perreau P; Joubaud F; Gardais J; Simard C
    Sem Hop; 1972 Jan; 48(5):355-9. PubMed ID: 4339308
    [No Abstract]   [Full Text] [Related]  

  • 31. Pseudohyperkalemia without reported haemolysis in a patient with chronic lymphocytic leukaemia.
    Chan JS; Baker SL; Bernard AW
    BMJ Case Rep; 2012 Jan; 2012():. PubMed ID: 22665715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of pseudohyperkalaemia and thrombocytosis.
    Seah TG; Lew TW; Chin NM
    Ann Acad Med Singap; 1998 May; 27(3):442-3. PubMed ID: 9777095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudohyperkalemia identified in a myelofibrosis patient exhibiting giant platelets and nucleated red blood cells.
    Duplessis C; Rakowski D; Yeung E; Hopkins M
    Clin Nephrol; 2007 Jul; 68(1):57-9. PubMed ID: 17703838
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
    Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
    Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
    [No Abstract]   [Full Text] [Related]  

  • 35. Pseudohyperkalemia in pediatric patients with newly diagnosed hematological malignancies.
    Li TC; Chan WC; Tsai MC; Tsai SF; Jan SL; Fu LS; Huang FL; Huang YC
    Pediatr Hematol Oncol; 2024 Oct; 41(7):470-479. PubMed ID: 38867542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous extramedullary hematopoiesis following splenectomy for idiopathic myelofibrosis.
    Hocking WG; Lazar GS; Lipsett JA; Busuttil RW
    Am J Med; 1984 May; 76(5):956-8. PubMed ID: 6720738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The development of a diffuse centroblastic lymphoma after splenectomy in a female patient with idiopathic myelofibrosis].
    Gallardo D; Berlanga J; Callis M; Grañena A
    Med Clin (Barc); 1995 Apr; 104(15):599. PubMed ID: 7769875
    [No Abstract]   [Full Text] [Related]  

  • 39. Spurious hyperkalaemia associated with severe thrombocytosis and leukocytosis.
    Ho AM; Woo JC; Kelton JG; Chiu L
    Can J Anaesth; 1991 Jul; 38(5):613-5. PubMed ID: 1934214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudohyperkalemia: Three Cases and a Review of Literature.
    Saleh-Anaraki K; Jain A; Wilcox CS; Pourafshar N
    Am J Med; 2022 Jul; 135(7):e150-e154. PubMed ID: 35398330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.